It has therefore been suggested that pro-inflammatory S100A9, which possesses intrinsic amyloidogenic properties as well as the ability to modulate Aβ aggregation, can serve as a link between the Alzheimer’s disease amyloid and neuroinflammatory cascades and as a prospective therapeutic target [18]. The gene discussed is S100A9; the disease is Alzheimer disease.